The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
Abstract
Background —Observational studies have shown that postmenopausal hormone therapy may increase, decrease, or have no effect on the risk of stroke. To date, no clinical trial has examined this question. To investigate the relation between estrogen plus progestin therapy and risk of stroke among postmenopausal women, we analyzed data collected from the Heart & Estrogen-progestin Replacement Study (HERS), a secondary coronary heart disease prevention trial. Methods and Results —Postmenopausal women (n=2763) were randomly assigned to take conjugated estrogen plus progestin or placebo. Primary outcomes for these analyses were stroke incidence and stroke death during a mean follow-up of 4.1 years. The number of women with strokes was compared with the number of women without strokes. A total of 149 women (5%) had 1 or more strokes, 85% of which were ischemic, resulting in 26 deaths. Hormone therapy was not significantly associated with risk of nonfatal stroke (relative hazard [RH] 1.18; 95% CI 0.83 to 1.66), fatal stroke (RH 1.61; 95% CI 0.73 to 3.55), or transient ischemic attack (RH 0.90; 95% CI 0.57 to 1.42). Independent predictors of stroke events included increasing age, hypertension, diabetes, current cigarette smoking, and atrial fibrillation. Black women were at increased risk compared with white women, and unexpectedly, body mass index was inversely associated with stroke risk. Conclusions —Hormone therapy with conjugated equine estrogen and progestin had no significant effect on the risk for stroke among postmenopausal women with coronary disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,305
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Meta-analysis of relation between cigarette smoking and stroke.
Shinton, R., & Beevers, G. (1989) · BMJ · doi:10.1136/bmj.298.6676.789 · Cited by 1,039
Decreased Mortality in Users of Estrogen Replacement Therapy
Henderson, B. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010095012 · Cited by 632
Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131702 · Cited by 601
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
Warlow, C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90086-1 · Cited by 371
Zhong, L., Goldberg, M. S., Gao, Y.-T., & Jin, F. (1999) · Epidemiology · doi:10.1097/00001648-199909000-00005 · Cited by 273
Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort
Finucane, F. F. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.1.73 · Cited by 245
Muir, J., Mant, D., Jones, L., & Yudkin, P. (1994) · BMJ · doi:10.1136/bmj.308.6924.308 · Cited by 231
Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysis
HUNT, K., VESSEY, M., & McPHERSON, K. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb02494.x · Cited by 228
Folsom, A. R., Mink, P. J., Sellers, T. A., Hong, C. P., Zheng, W., & Potter, J. D. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.8_pt_1.1128 · Cited by 200
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden
Falkeborn, M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.10.1201 · Cited by 195
Sacco, R. L., Kargman, D. E., & Zamanillo, M. C. (1995) · Neurology · doi:10.1212/wnl.45.4.659 · Cited by 193
EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT
Sturgeon, S. R., Schairer, C., Brinton, L. A., Pearson, T., & Hoover, R. N. (1995) · Epidemiology · doi:10.1097/00001648-199505000-00006 · Cited by 188
Potshuma, W. F. M., Westendorp, R. G. J., & Vandenbroucke, J. P. (1994) · BMJ · doi:10.1136/bmj.308.6939.1268 · Cited by 162
Njølstad, I., Arnesen, E., & Lund‐Larsen, P. G. (1996) · Circulation · doi:10.1161/01.cir.94.11.2877 · Cited by 145
Hormone replacement therapy and risk of non-fatal stroke
Pedersen, A. T., Lidegaard, Ø., Kreiner, S., & Ottesen, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06005-4 · Cited by 142
Hormone Replacement Therapy and the Risk of Stroke
Falkeborn, M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410100035005 · Cited by 135
Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study.
Lindenstrøm, E., Boysen, G., & Nyboe, J. (1993) · Stroke · doi:10.1161/01.str.24.10.1468 · Cited by 130
Dyken, M. L. (1991) · Springer eBooks · doi:10.1007/978-1-4757-4226-8_6 · Cited by 113
Johnson, J. L., Heineman, E. F., HEISS, G. M., Hames, C. G., & Tyroler, H. A. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114230 · Cited by 112
Biller, J., & Love, B. B. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30274-7 · Cited by 111
Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy
Petitti, D. B., Sidney, S., Quesenberry, C. P., & BERNSTEIN, A. L. (1998) · Stroke · doi:10.1161/01.str.29.1.23 · Cited by 100
Cause-Specific Mortality in Women Receiving Hormone Replacement Therapy
Schairer, C., Adami, H., Hoover, R. N., & Persson, I. R. (1997) · Epidemiology · doi:10.1097/00001648-199701000-00010 · Cited by 99
Hormone Replacement Therapy – With or Without Added Progestin-and Which Progestin?
grodstein, F., Stampfer, M. J., Falkeborn, M., Naessén, T., & Persson, I. (1999) · Epidemiology · doi:10.1097/00001648-199909000-00001 · Cited by 93
Paffenbarger, R. S., NOTKIN, J., Krueger, D. E., Wolf, P. A., Thorne, M. C., LeBauer, E. J., & Williams, J. L. (1966) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.56.6.962 · Cited by 64
Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan.
Carman, W. J., Barrett-Connor, E. L., Sowers, M., & Khaw, K. (1994) · Circulation · doi:10.1161/01.cir.89.2.703 · Cited by 53
Self-citationHormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease
Pan, C. X., & Boal, J. (1999) · JAMA · doi:10.1001/jama.281.9.794 · Cited by 36
SUBCUTANEOUS FATNESS AND MORTALITY1
Comstock, G. W., Kendrick, M. A., & Livesay, V. T. (1966) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120606 · Cited by 35
The Influence of Occupational Activity on the Menstrual Cycle and Fecundability
Weinberg, C. R. (1994) · Epidemiology · doi:10.1097/00001648-199407000-00019 · Cited by 34
Subcutaneous Fatness AND Mortality
Comstock, G. W., Kendrick, M. A., & Livesay, V. T. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn325 · Cited by 34
Hormone Replacement Therapy and Stroke Risk in Older Women
Fung, M. M., Barrett-Connor, E. L., & BETTENCOURT, R. R. (1999) · Journal of Women s Health · doi:10.1089/jwh.1999.8.359 · Cited by 27
Self-citationAdiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study.
DiPietro, L., Ostfeld, A. M., & Rosner, G. L. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.1.14 · Cited by 26
Cited by
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Metadata
- Authors
- Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B.
- Venue
- Circulation
- Published
- 2001-02-06
- Volume
- 103
- Issue
- 5
- Pages
- 638-642
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1997512708
- Cited by
- 403
- References
- 37
- FWCI
- 28.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.